Expression and hypoxia-responsiveness of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 in mammary gland malignant cell lines.

作者: Oleksandr H Minchenko , Iryna L Opentanova , Tsutomu Ogura , Dmytro O Minchenko , Sergiy V Komisarenko

DOI: 10.18388/ABP.2005_3402

关键词: Molecular biologyIsozymePFKFB4Hypoxia (medical)Gene expressionCell cultureBiologyWarburg effectGLUT1Cancer cell

摘要: Recently, we have shown that PFKFB4 gene which encodes the testis isoenzyme of PFKFB is also expressed in prostate and hepatoma cancer cell lines. Here studied expression hypoxic regulation several malignant lines from a female organ--the mammary gland. Our studies clearly demonstrated mRNA gland cells (MCF-7 T47D lines) normoxic conditions hypoxia strongly induces it expression. To better understand mechanism expression, used dimethyloxalylglycine, specific inhibitor HIF-1alpha hydroxylase enzymes, increases levels mimics effect hypoxia. It was observed MCF7 highly responsive to suggesting responsiveness these regulated by HIF-1 proteins. Moreover, desferrioxamine cobalt chloride, mimic chelating or substituting for iron, had similar stimulatory on mRNA. In other (BT549, MDA-MB-468, SKBR-3) induced mRNA, but variable degrees. The induction equivalent PFKFB3, Glut1, VEGF, are known HIF-1-dependent genes. Hypoxia dimethyloxalylglycine increased protein all except MDA-MB-468. Through site-specific mutagenesis 5'-flanking region response could be limited. Thus, this study provides evidence responds via an dependent mechanism. PFKFB3 has significant role Warburg found cells.

参考文章(39)
A J Giaccia, J M Brown, The unique physiology of solid tumors: opportunities (and problems) for cancer therapy Cancer Research. ,vol. 58, pp. 1408- 1416 ,(1998)
J. M. Gleadle, B. L. Ebert, J. D. Firth, P. J. Ratcliffe, Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. American Journal of Physiology-cell Physiology. ,vol. 268, ,(1995) , 10.1152/AJPCELL.1995.268.6.C1362
Mark H. RIDER, Luc BERTRAND, Didier VERTOMMEN, Paul A. MICHELS, Guy G. ROUSSEAU, Louis HUE, 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis Biochemical Journal. ,vol. 381, pp. 561- 579 ,(2004) , 10.1042/BJ20040752
David Lando, Daniel J Peet, Dean A Whelan, Jeffrey J Gorman, Murray L Whitelaw, Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. ,vol. 295, pp. 858- 861 ,(2002) , 10.1126/SCIENCE.1068592
Ryuzo Sakakibara, Tomonari Okudaira, Kunio Fujiwara, Mie Kato, Takafumi Hirata, Shigeki Yamanaka, Makoto Naito, Masashi Fukasawa, Tissue Distribution of Placenta-Type 6-Phosphofructo- 2-kinase/Fructose-2,6-bisphosphatase Biochemical and Biophysical Research Communications. ,vol. 257, pp. 177- 181 ,(1999) , 10.1006/BBRC.1999.0429
Christopher J. Schofield, Peter J. Ratcliffe, Oxygen sensing by HIF hydroxylases Nature Reviews Molecular Cell Biology. ,vol. 5, pp. 343- 354 ,(2004) , 10.1038/NRM1366
David A. Okar, Alex J. Lange, Ànna Manzano, Aurèa Navarro-Sabatè, Lluı̀s Riera, Ramon Bartrons, PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends in Biochemical Sciences. ,vol. 26, pp. 30- 35 ,(2001) , 10.1016/S0968-0004(00)01699-6